USANA Q1 net sales $273M (-11% YoY), EPS $1.15 (-21% YoY); cuts FY2022 guidance

USANA HEALTH SCIENCES INC

2022-Q1 EPS reported $1.15 revenue$272,867,000

Net sales $272.9M, down 11% YoY; diluted EPS $1.15, down 21% from $1.45.
Asia Pacific net sales $218.4M (-13% YoY); Greater China down 10%; Southeast Asia Pacific down 24%.
Active customers 552,000, down 11% YoY; Americas & Europe active customers down 10%.
Revised FY2022 outlook: net sales $1.1-1.2B (was $1.125-1.225B), EPS $5.00-5.70 (was $5.25-6.00).
Company repurchased $25M in shares in Q1; $83M remaining under authorization; cites China COVID lockdowns as headwind.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.